NCT05704166View on ClinicalTrials.gov

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
Acute Lung InjuryPrevention
Interventions
DRUG

Pirfenidone/Placebo

Patients were given drugs orally one week before radiotherapy, 200mg/ time, 3 times a day in the first week; 300mg/ time 3 times daily for the second week and 400mg/ time 3 times daily for the third to eighth week. Take it after a meal.

Trial Locations (1)

Unknown

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
collaborator

Beijing Continent Pharmaceutical Co, Ltd.

INDUSTRY

lead

Fujian Medical University Union Hospital

OTHER